National and Kapodistrian University of Athens
Διερεύνηση της ετήσιας επίπτωσης της Langerhans Cell Histiocytosis (LCH) και του επιπολασμού της γονιδιακής μετάλλαξης BRAF σε ενήλικες Έλληνες ασθενείς με LCH
Abstract
dc:descriptionLangerhans cell histiocytosis (LCH) is a rare condition, characterized by tissue infiltration with cells that resemble Langerhans cells, a specialized subset of dendritic cells, which populates the epidermal layer of the skin and the mucosal tissues. LCH can affect any organ and is considered an inflammatory myeloid neoplasm with mutations in the MAPK/ERK pathway being found in all histological examinations. The BRAFV600E is the most common mutation, with a frequency of up to 60% in pediatric studies and an association with the disease extent, number of affected systems and severity of clinical manifestations.LCH is diagnosed in all age groups, but is most commonly seen in children with a mean age of diagnosis at 3 years old and an estimated annual incidence of up to 8.9 cases per million population in children under 15 years old. In adults the disease is rarer and is considered an ''orphan disease'' with an estimated incidence of 1-2 cases per million population and mean age at diagnosis at 33 years old. However, this estimated annual incidence hasn't been further investigated through an organized epidemiological study in the adult population.The aim of this research study is the prospective recording of the annual incidence of LCH in adults for the first time in literature and the investigation of the presence of the BRAFV600E mutation in Greek adults with LCH as well as its association with clinical parameters, such as the disease extent, age at diagnosis, gender, organ involvement, response to initial treatment (chemotherapy, surgical excision, smoking cessation, local radiotherapy or combination therapy), presence of diabetes insipidus, history of malignancy and relapse risk.The recording of new cases took place from the 1st of September 2018 until the 31st of August 2019 after frequent communication with the vast majority of pathology laboratories in theNational Health System in Greece (85%). The annual incidence of the disease in adults in Greece was estimated at 1.58 per million population with a mean age at diagnosis at 43.5 years and a female to male ratio of 1.34.The BRAF V600E mutation was found in 39% of the patients who are followed up in the LCH adult clinic and agreed to take part in the study. Upon written consent, DNA was isolated from 40 formalin fixed, paraffin-embedded tissue blocks, of which 31 yielded sufficient DNA for molecular analysis with PCR. The BRAFV600E mutation was found in 12 patients (38,71%) with the majority being females (83.3%), while 13 patients (41,94%) did not carry the mutation. In 6 patients (2 men), (19,35%), genotyping qPCR studies failed to meet the technical standards required for definitive interpretation of results.There was no statistically significant association of the presence of the mutation with age at diagnosis, organ involvement, disease extent (single system or multi-system), response to initial treatment, development of diabetes insipidus and relapse risk.As targeted therapies become more widespread in the management of LCH, further studies are needed for the discovery of the full spectrum of mutations implicated in disease pathogenesis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stathi, Dimitra
- Στάθη, Δήμητρα
Subjects
dc:subject × 20- ΙΣΤΙΟΚΥΤΤΑΡΩΣΗ
- Ιστιοκύττωση Χ
- BRAF μεταλλάξεις
- Επιπολασμός και επίπτωση
- Ενήλικες ασθενείς
- Histiocytosis
- LANGERHAN'S CELLS
- BRAF mutations
- Prevalence and incidence
- ADULTS PREVALENCE
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Γενετική ανθρώπου
- Επιστήμες Υγείας
- Επιδημιολογία
- Basic Medicine
- Medical and Health Sciences
- Human genetics
- Health Sciences
- Epidemiology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52860